Sek Kathiresan MD
@skathire
CEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
ID:635833627
http://www.vervetx.com 15-07-2012 02:25:37
25,5K Tweets
30,3K Followers
990 Following
Follow People
We often get asked:
We have such great meds for cholesterol already. What’s the unmet need?
Challenge: time on therapy is cut short by so many barriers in our system
👇🏽highlights one reason for short time on therapy and its adverse consequences.
Amitabh Chandra
No matter how grown up they get, nothing better than ice cream with your little girl. ❤️
Van Leeuwen Ice Cream
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography. A State-of-the-Art Review just published in #EHJ
European Society of Cardiology European Society of Cardiology Journals #CardioTwitter #atherosclerosis #CCTA Dr. Deepak L. Bhatt Nick Nurmohamed
academic.oup.com/eurheartj/adva…
Honored to celebrate this dedicated, hard-working group who represent our program at the highest level inside and outside the classroom on #NationalStudentAthleteDay 👊
#FightOnPenn 🔴🔵⚽️
Excellent/transparent interview by Brad Loncar BiotechTV of Sek Kathiresan MD re: Verve Therapeutics data. Completely agree with Sek’s assessment here and reasons to move forward with next gen LNP.
Highlights, again, that future of genetic medicines depends on delivery, delivery, delivery!
Today, Verve Therapeutics is announcing updates to our PCSK9 program:
1. voluntarily pausing enrollment in the Heart-1 trail of VERVE-101
2. prioritizing clinical development of VERVE-102 which uses a different LNP delivery system
3. announcing clinical trial application have been cleared…